Earningsreport

Q2/2017 12/31/2016 EPS -0.080 ZacksConsensus N/A ActVsEst N/A - Beat

CONTRAVIR PHARMACEUTICALS INC  (CTRV) 
US:NASDAQ Investor Relations: ir.contravir.com/investor-relations